EMERGENCY:Acute behavioural crisis or sudden deterioration —call040-46324365immediately — 24 hours, 7 days— 24/7
Frontotemporal Dementia (Pick's Disease): When Personality Changes Are a Brain Disease, Not a Psychiatric Problem
Expert Frontotemporal Dementia diagnosis at KIMS Neuroscience, Hyderabad. FTD is often mistaken for depression, bipolar disorder, midlife crisis, or relationship problems when the real cause is a progressive brain disease. Early specialist diagnosis changes everything.
Frontotemporal Dementia is the most common cause of dementia in people under 60, caused by progressive degeneration of the frontal and temporal lobes — the brain regions controlling personality, behaviour, language, empathy, and judgement. Unlike Alzheimer's Disease, memory is often preserved in early FTD. Instead, patients develop profound behavioural and personality changes (in bvFTD) or progressive language impairment (in PPA variants). FTD is frequently misdiagnosed as depression, bipolar disorder, or a personality disorder for years — the average time from first symptom to correct diagnosis is 3–5 years. Specialist assessment at KIMS Neuroscience provides the most accurate diagnosis available.
- What it is
- Most common dementia under age 60. Frontal and temporal lobe degeneration causes personality change, behaviour change, or language impairment — not primarily memory loss in early stages.
- Who it affects
- Approximately 60% of patients are aged 45–64 — working age, parents of children, people at the height of their careers.
- Most misdiagnosed dementia
- Average 3–5 years from first symptom to correct diagnosis. Commonly misdiagnosed as depression, bipolar disorder, or personality disorder. Memory tests are often NORMAL in early FTD.
- Three variants
- bvFTD (behavioural — most common) · svPPA (semantic — loses word meanings) · nfvPPA (non-fluent — effortful, halting speech)
- Genetic risk
- 40% have a family history · Three main genes: C9orf72 (also causes ALS) · MAPT · GRN · Each is autosomal dominant (50% inheritance risk)
- Diagnosis at KIMS
- Neuropsychological assessment · FDG-PET (characteristic frontal hypometabolism) · Asymmetric frontal MRI atrophy · Genetic testing for familial cases
- When to seek help
- Unexplained personality change in person aged 40–65 · disinhibition · apathy · loss of empathy · repetitive behaviours · eating changes · progressive speech difficulty
| Fact | Details |
|---|---|
| Medical classification | Frontotemporal lobar degeneration · Most common dementia under age 60 · Tau or TDP-43 pathology |
| Three variants | bvFTD (behavioural — most common) · svPPA (semantic PPA) · nfvPPA (non-fluent PPA) |
| Six bvFTD criteria | Disinhibition · apathy · loss of empathy · perseveration · hyperorality · executive dysfunction |
| Genetic risk | 40% have family history · C9orf72 (also causes ALS) · MAPT · GRN · autosomal dominant (50% risk) |
| Diagnosis at KIMS | Neuropsychological assessment · FDG-PET (frontal hypometabolism) · Asymmetric frontal MRI atrophy · Genetic testing |
| FTD–ALS overlap | 12–13% of FTD patients develop ALS-type motor neuron involvement |
| When to seek help | Unexplained progressive personality/behaviour change aged 40–65 · disinhibition · apathy · language difficulty |
EMERGENCY:Critical Note: FTD is frequently misdiagnosed as depression, bipolar disorder, or a psychiatric condition for years —call040-46324365immediately — 24 hours, 7 days— 24/7
About This Condition
What Is Frontotemporal Dementia?
Frontotemporal Dementia also known as FTD, Pick's Disease, or Frontotemporal Lobar Degeneration is a family of progressive brain disorders caused by the deterioration of neurons in the frontal and temporal lobes of the brain. These are the regions that govern personality, behaviour, judgement, empathy, social conduct, language, and emotional regulation. When they degenerate, the result is a profound and often bewildering change in who the person is long before any significant memory loss appears.
Pick's disease is the most common cause of dementia in patients under 60 years of age, and roughly 60% of people with FTD are aged 45 to 64 working professionals, parents of teenage children, people at the height of their careers and family responsibilities. This is what makes FTD so devastating and so frequently misunderstood: a 52-year-old who begins behaving in uncharacteristically disinhibited, antisocial, or apathetic ways is rarely first thought to have a neurodegenerative condition. They are far more likely to be suspected of depression, bipolar disorder, a mid-life crisis, substance misuse, or personality disorder.
Because FTD is rare and not well understood, it is sometimes misdiagnosed as Alzheimer's disease or other types of dementia and the symptoms are often misunderstood. The average time from first symptom to correct diagnosis is reported in published studies as three to five years. During those years, patients receive the wrong treatment, families are told to manage what is framed as a behavioural problem rather than a medical one, and the opportunity for accurate prognosis, appropriate planning, and correct pharmacological management is lost.
At KIMS Neuroscience, Hyderabad, our specialist neurologists and neuropsychologists have the experience and diagnostic toolkit to identify Frontotemporal Dementia accurately giving patients and families the clarity they need, and the appropriate care they deserve.
Book a Consultation
Speak directly with our specialist team. No referral required. Monday to Saturday.
040-44885000International enquiries: info@kimsneurosciences.comWhat Are the Symptoms of Frontotemporal Dementia?
FTD presents differently depending on which subtype and which brain region is most affected. There are three main clinical variants, and they produce strikingly different symptom profiles.
Subtype 1: Behavioural Variant FTD (bvFTD) — the most common form
Behavioural variant FTD — previously known as Pick's disease is the most common of the FTD types, diagnosed four times as often as the language variants. It is defined by prominent, progressive changes in behaviour and personality changes that families typically describe as the person "becoming someone else."
The six diagnostic behavioural criteria are:
• Disinhibition socially inappropriate behaviour that would previously have been unthinkable: making offensive comments to strangers, touching people without consent, shoplifting, or inappropriate sexual behaviour. This is not a choice. The brain regions that normally inhibit such impulses have degenerated.
• Apathy and inertia, a profound loss of motivation, initiative, and interest in activities and people the person previously cared about deeply. Unlike depression, this apathy is not accompanied by sadness the person is not unhappy; they simply do not care. Families often describe it as the person "switching off."
• Loss of empathy and sympathy, an inability to recognise or respond to others' emotional states. The person may seem cold, indifferent, or callous in situations that would previously have moved them deeply. A parent may stop showing affection to their children. A spouse may be completely unmoved by news of a family bereavement.
• Perseverative, stereotyped, or compulsive behaviours repetitive movements or rituals (tapping, humming, rubbing), rigid adherence to routines, and repetitive speech patterns. Collecting or hoarding behaviours are common.
• Hyperorality and dietary changes binge eating, a sudden preference for sweet foods, putting non-food items in the mouth, or a dramatic change in food preferences. Weight gain is common. This reflects the degeneration of the orbitofrontal cortex.
• Executive dysfunction impaired planning, sequencing, decision-making, and cognitive flexibility. Executive dysfunction occurs while episodic memory and visuospatial skills are characteristically spared meaning the person may have significant behavioural changes but can still recall recent events correctly, which further obscures the diagnosis.
Subtype 2: Semantic Variant Primary Progressive Aphasia (svPPA)
This variant primarily affects the temporal lobes' language networks, causing a progressive loss of the meaning of words and concepts. The person's speech remains fluent and grammatically correct, but they lose the ability to retrieve and understand words especially nouns. They may ask repeatedly what common objects are called, or replace specific words with generic ones ("that thing," "what you call it"). Face and object recognition can also deteriorate. Behaviour and memory are relatively preserved in the early stages.
Subtype 3: Non-Fluent Variant Primary Progressive Aphasia (nfvPPA)
This variant causes progressive difficulty producing speech effortful, halting, grammatically simplified output, with preserved comprehension in the early stages. Over time, speech production becomes increasingly laboured until the person may become largely mute. Unlike svPPA, they understand words and sentences until late in the disease.
The FTD-ALS overlap
About 12–13% of people with behavioural variant FTD develop motor neuron disease, a combination of FTD and ALS (Amyotrophic Lateral Sclerosis) that is clinically and genetically linked through the C9orf72 gene mutation. When limb weakness, muscle wasting, or fasciculations develop in a person with known FTD, urgent neurological review for motor neuron disease is essential. Conversely, cognitive or behavioural changes in a patient with ALS should prompt evaluation for FTD.
What Causes Frontotemporal Dementia?
FTD is caused by the degeneration of frontal and temporal lobe neurons, driven by the accumulation of abnormal proteins — most commonly tau protein (in approximately 45% of cases) and TDP-43 protein (in approximately 50% of cases). The two most prominent underlying diseases are a group of brain disorders involving the protein tau and a group involving the protein TDP-43.
Protein accumulation and brain damage
At the molecular level, the specific protein involved determines the neuropathological subtype, but from a clinical perspective, what matters more is which brain regions are most affected and in what order — because this determines the clinical variant (behavioural, semantic, or non-fluent).
Damage to the frontal lobes mainly affects personality, judgement, empathy, and behaviour, while damage to the temporal lobes affects language, speech production, and understanding of words and meaning.
Genetic factors — stronger than in Alzheimer's
FTD has a substantially stronger genetic component than most other dementias. Approximately 40% of FTD patients have a positive family history of FTD or a related disorder.
Three genes account for the majority of familial cases:
• C9orf72 — the most common genetic cause of both familial FTD and familial ALS. People carrying this mutation may develop FTD, ALS, or both.
• MAPT — mutations in the microtubule-associated protein tau gene cause autosomal dominant FTD with prominent behavioural symptoms and parkinsonism.
• GRN (Progranulin) — mutations cause autosomal dominant FTD with TDP-43 pathology. Reduced protein production is the disease mechanism.
Inheritance and family risk
These three mutations are inherited in an autosomal dominant pattern, meaning each child of an affected carrier has a 50% chance of inheriting the mutation.
Genetic counselling is therefore strongly recommended for families in which FTD has affected multiple generations or a first-degree relative under the age of 65.
Sporadic cases and other risk factors
In approximately 60% of FTD cases, there is no family history and no identifiable gene mutation. The cause of neurodegeneration in these sporadic cases remains incompletely understood.
Risk factors include:
• Age — though FTD occurs at younger ages than most dementias, risk increases with age
• Family history of FTD, ALS, or related disorders
• Certain identified gene mutations (C9orf72, MAPT, GRN)
• Prior head injury has been suggested as a risk factor in some studies, though evidence is less established than for Alzheimer's
Diagnosis at KIMS
How Is Frontotemporal Dementia Diagnosed at KIMS?
Accurate diagnosis of FTD requires a clinician experienced in differentiating it from Alzheimer's Disease, psychiatric disorders, and other neurodegenerative conditions. The gradual onset and progression of subtle behavioural changes or language deficits commonly leads to a long delay between the onset of symptoms and time of presentation to a neurologist. At KIMS Neuroscience, Hyderabad, we apply the current international consensus diagnostic criteria and combine clinical assessment with advanced neuroimaging and neuropsychological evaluation.
Detailed behavioural and psychiatric history
A thorough account is taken from both the patient and critically, a family member or close associate who has known the person well for years. FTD patients frequently lack insight into their own behavioural changes; they do not recognise that anything is wrong. The history must specifically probe for the six behavioural diagnostic criteria described above disinhibition, apathy, loss of empathy, compulsive behaviours, hyperorality, and executive dysfunction. The age of onset, the tempo of progression, and any family history of dementia, ALS, or psychiatric disorders are documented.
Neurological and cognitive examination
Standard cognitive screening tests MMSE, MoCA are often near-normal in early FTD, which is one reason the diagnosis is missed. FTD-specific neuropsychological tests targeting executive function, social cognition, and frontal lobe tasks are far more sensitive. The neurological examination assesses for any signs of motor neuron disease, parkinsonism, or other movement abnormalities.
Comprehensive neuropsychological assessment
A full neuropsychological battery administered by our clinical neuropsychologist characterises the patient's specific profile of impairment across all cognitive domains identifying the frontal-executive deficits and relatively preserved memory and visuospatial function characteristic of bvFTD, or the language-specific deficits of the PPA variants. This profile is essential for correct subtype diagnosis and for distinguishing FTD from Alzheimer's Disease.
MRI brain — with frontal and temporal lobe focus
In FTD, MRI reveals disproportionate atrophy of the frontal and/or temporal lobes, a pattern distinctly different from the posterior hippocampal-predominant atrophy of Alzheimer's Disease. In the language variants, asymmetric temporal lobe atrophy is characteristic. In early disease, MRI may appear relatively normal making the clinical history and neuropsychological profile the primary diagnostic tools.
FDG-PET scan
FDG-PET imaging measuring regional cerebral glucose metabolism is among the most sensitive diagnostic tools for FTD, revealing characteristic frontal and anterior temporal hypometabolism before structural changes are visible on MRI. At KIMS Neuroscience, FDG-PET is available and is used in diagnostically ambiguous cases or where early diagnosis is particularly important.
Genetic testing (selected cases)
When there is a family history of FTD, ALS, or a related disorder, or when FTD presents before age 60, genetic testing for C9orf72, MAPT, and GRN mutations is offered with pre-test genetic counselling. A positive result has implications not only for the patient but for first-degree relatives who may wish to consider predictive testing.
Treatment
Treatment of Frontotemporal Dementia at KIMS
There is currently no disease-modifying treatment for FTD and no approved pharmacological therapy that slows its progression. Management is entirely symptomatic targeting the behavioural, language, and functional consequences of the disease to improve quality of life and reduce the burden on carers.
Pharmacological management of behavioural symptoms
SSRIs (selective serotonin reuptake inhibitors) particularly sertraline, fluvoxamine, and paroxetine are most commonly used pharmacological agents in FTD. Evidence supports their use for reducing disinhibition, compulsive behaviours, and agitation. They are generally well tolerated, do not worsen cognition. Trazodone has shown benefit for reducing behavioural disturbance FTD in clinical trials. Memantine is sometimes used though evidence in FTD is limited. Antipsychotics are used cautiously for severe agitation or psychosis they must be prescribed at low doses and monitored carefully, as patients with FTD may have overlapping Lewy body pathology or motor sensitivity.
Important note on Alzheimer's medications
Acetylcholinesterase inhibitors (donepezil, rivastigmine, galantamine) the mainstay of Alzheimer's treatment are generally not beneficial in FTD and may worsen behavioural symptoms in some patients. This is another reason why accurate diagnosis at KIMS matters clinically.
Non-pharmacological behavioural management
Structured routine, environmental modification (reducing stimulation disinhibited patients; increasing engagement in apathetic ones), behavioural management training for carers are the most effective tools. Our neuropsychology team at KIMS provides tailored behavioural management guidance directly to families with practical strategies for managing the specific behaviours affecting each patient.
Speech and language therapy
For patients with primary progressive aphasia, specialist speech and language therapy focuses on maintaining communication for as long as possible developing augmentative and alternative communication (AAC) strategies before verbal speech is lost. Early referral to our speech therapy team is strongly recommended for language-variant FTD.
Physiotherapy and occupational therapy
As FTD progresses, motor symptoms may emerge particularly in FTD-ALS overlap, or in variants where parkinsonism develops. Physiotherapy for falls prevention, gait modification, and mobility maintenance, and occupational therapy for home adaptation and daily functioning, are integral to care.
Carer education and psychological support
FTD imposes a uniquely devastating burden on families. The behavioural symptoms disinhibition, loss of empathy, compulsive behaviours are profoundly distressing and frequently misunderstood by neighbours, extended family, and employers. Families often experience social isolation, shame, and grief grieving not the death of the person, but the loss of who they were. At KIMS Neuroscience, we treat this directly: structured carer education at every stage, psychological support referral, and a clear clinical contact for urgent queries between appointments.
When Should You Seek Specialist Assessment for FTD?
The most important message for families: If a person's behaviour has changed fundamentally and inexplicably and multiple psychiatric explanations have been tried without success the brain must be evaluated. FTD is a neurological condition that looks psychiatric. The correct diagnosis leads to the correct management and, crucially, to accurate prognosis and legal and financial planning while the person still has capacity.
At KIMS Neuroscience, Hyderabad, we accept direct patient and family referrals. You do not need to have a neurology referral from a psychiatrist. If you believe a psychiatric diagnosis doesn't fully explain what you are seeing, come and discuss it with our team.
Sudden or progressive personality change — particularly disinhibition (saying or doing inappropriate things), apathy (complete loss of interest and motivation), or loss of empathy
Socially inappropriate behaviour that is completely out of character and not explained by a major life stress or psychiatric history
Repetitive or compulsive behaviours — rituals, collecting, stereotyped phrases
Unusual dietary changes — binge eating, craving sweets, weight gain without lifestyle change
Progressive difficulty finding words, naming objects, or understanding the meaning of words, despite normal comprehension of non-verbal information
Effortful, halting speech that has worsened progressively over months
A family history of FTD, ALS, or early dementia, and any emerging cognitive or behavioural symptoms
Prognosis — What to Expect with Frontotemporal Dementia
FTD is a progressive condition, and the prognosis depends significantly on the subtype and the underlying genetic and neuropathological cause. While FTD can shorten life on average to about six to eight years from diagnosis, some people live for as long as 20 years. Rapidly progressive forms particularly FTD-ALS overlap have a far shorter survival, often 2–3 years from symptom onset of the motor symptoms.
Behavioural variant FTD tends to progress more rapidly than the language variants. The language variants particularly nfvPPA can progress slowly over many years, with the patient losing speech but maintaining other faculties for a prolonged period.
The trajectory of FTD is not simply one of progressive cognitive decline. Because the frontal lobes govern judgment, impulse control, and social behaviour, the disease progressively removes the person's capacity for safe, independent decision-making often many years before they develop the memory impairment that triggers formal mental capacity assessments. Early, proactive legal and financial planning power of attorney, advance care directives is strongly recommended at KIMS immediately following diagnosis, while the person still has legal capacity.
For families, the journey with FTD is often described as among the most difficult of any dementia not because the decline is more rapid than other conditions, but because the person's personality and social identity can be altered so profoundly, so early. The person you knew may seem to have gone long before the person's body fails. Acknowledging this and getting support through it is as important as any clinical intervention. The KIMS Neuroscience team and our partner social and psychological services are here for that journey.
Related Conditions
Frontotemporal Dementia belongs to a broader family of neurodegenerative and movement-related disorders:
FAQs
Frequently Asked Questions
Has a family member's personality changed in a way that doesn't feel like depression or a psychiatric problem?
Frontotemporal Dementia is the most common cause of dementia under 60 and is almost always initially mistaken for something else. The earlier it is correctly diagnosed, the sooner the right management begins and the better placed the family is to plan ahead. Book a specialist cognitive assessment at KIMS Neuroscience, Hyderabad.
International enquiries: info@kimsneurosciences.com